About: http://webisa.webdatacommons.org/285990697

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	We are also exploring REVLIMID???s activity in other hematological malignancies, as well as in solid tumors, including prostate and thyroid cancers.
http://www.w3.org/ns/prov#wasQuotedFrom	seekingalpha.com